Dissociation of cerebrospinal fluid amyloid- and tau levels in patients with prolonged posttraumatic disorders of consciousness

被引:9
|
作者
Bagnato, Sergio [1 ,2 ]
Andriolo, Maria [3 ]
Boccagni, Cristina [1 ,2 ]
Sant'Angelo, Antonino [1 ,2 ]
D'Ippolito, Maria Enza [3 ]
Galardi, Giuseppe [1 ,2 ]
机构
[1] Giuseppe Giglio Fdn, Unit Neurophysiol, Rehabil Dept, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[2] Giuseppe Giglio Fdn, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy
[3] Giuseppe Giglio Fdn, Clin Pathol & Microbiol Lab, Cefalu, Italy
关键词
Amyloid beta; traumatic brain injury; total tau; phosphorylated tau; vegetative state; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; DEMENTIA; RISK; BIOMARKERS; INFLAMMATION; CONCORDANCE; POPULATION; PATHOLOGY;
D O I
10.1080/02699052.2018.1479042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Traumatic brain injury (TBI) is a major risk factor for Alzheimer's disease (AD). Although the mechanisms that lead to AD after a TBI are unclear, we hypothesize that changes in amyloid- (A) metabolism and abnormal tau phosphorylation are reasonable candidates.Objective: To investigate A and tau dynamics in the chronic phase of TBI.Methods: We evaluated A(1-42), total tau (t-tau), and phosphorylated tau (p-tau) levels in the cerebrospinal fluid (CSF) of 15 patients who developed a prolonged disorder of consciousness after a severe TBI (mean time from TBI 271.6176.5days).Results: Reduced A(1-42) levels (median 258pg/ml, range 90-833.6) were observed in 14/15 patients (93.3%) with severe post-TBI disorders of consciousness. These CSF analysis data did not correlate with time since TBI or with the patients' level of consciousness as determined by the Coma Recovery Scale Revised. Normal t-tau levels (median 95.2 pg/ml, range 52-256.9) were found in all patients. Normal p-tau levels (median 22.2pg/ml, range 14-72) were observed in 14/15 patients, with just a single patient having a slightly increased p-tau level.Conclusion: The present findings show that A and tau are differently affected in the chronic phase of severe TBI.
引用
收藏
页码:1056 / 1060
页数:5
相关论文
共 50 条
  • [31] Tau and β-amyloid levels in cerebrospinal fluid of patients with dementia with lewy bodies in comparison with Alzheimer's disease
    Gómez-Tortosa, E
    Yébenes, JG
    Jiménez-Díaz, FJ
    Gonzalo, I
    Fanjul, S
    Cemillán, F
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S382 - S382
  • [32] Tau protein and beta amyloid in cerebrospinal fluid in patients with multiple sclerosis
    Talab, R
    Valis, M
    Andrys, C
    Talabova, M
    Krejsek, J
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 189 - 189
  • [33] Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
    Heiko Braak
    Henrik Zetterberg
    Kelly Del Tredici
    Kaj Blennow
    Acta Neuropathologica, 2013, 126 : 631 - 641
  • [34] Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease
    Santangelo, Roberto
    Cecchetti, Giordano
    Bernasconi, Maria Paola
    Cardamone, Rosalinda
    Barbieri, Alessandra
    Pinto, Patrizia
    Passerini, Gabriella
    Scomazzoni, Francesco
    Comi, Giancarlo
    Magnani, Giuseppe
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (01) : 183 - 199
  • [35] Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
    Braak, Heiko
    Zetterberg, Henrik
    Del Tredici, Kelly
    Blennow, Kaj
    ACTA NEUROPATHOLOGICA, 2013, 126 (05) : 631 - 641
  • [36] Interactions between Amyloid-β and Tau in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Alzheimer's Disease
    Kristofikova, Zdena
    Ricny, Jan
    Kolarova, Michaela
    Vyhnalek, Martin
    Hort, Jakub
    Laczo, Jan
    Sirova, Jana
    Ripova, Daniela
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 : S91 - S98
  • [37] Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-β38/40/42 in Frontotemporal Dementias and Primary Progressive Aphasias
    Bibl, Mirko
    Mollenhauer, Brit
    Lewczuk, Piotr
    Esselmann, Hermann
    Wolf, Stefanie
    Otto, Markus
    Kornhuber, Johannes
    Ruether, Eckart
    Wiltfang, Jens
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (01) : 37 - 44
  • [38] False Recognition Correlates with Amyloid-β1-42 but not with Total Tau in Cerebrospinal Fluid of Patients with Dementia and Mild Cognitive Impairment
    Hildebrandt, Helmut
    Haldenwanger, Andreas
    Eling, Paul
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (01) : 157 - 165
  • [39] Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders
    Shafaati, Marjan
    Solomon, Alina
    Kivipelto, Mila
    Bjorkhem, Ingemar
    Leoni, Valerio
    NEUROSCIENCE LETTERS, 2007, 425 (02) : 78 - 82
  • [40] Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
    Gisslen, Magnus
    Krut, Jan
    Andreasson, Ulf
    Blennow, Kaj
    Cinque, Paola
    Brew, Bruce J.
    Spudich, Serena
    Hagberg, Lars
    Rosengren, Lars
    Price, Richard W.
    Zetterberg, Henrik
    BMC NEUROLOGY, 2009, 9